MVA analysis of factors associated with 6-month ORR and FFS
| Characteristic . | 6-mo ORR (CR/PR) . | FFS . | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| n . | Event, n . | OR . | 95% CI . | P value . | n . | Event, n . | HR . | 95% CI . | P value . | |
| Liver involvement | 131 | 59 | 5.49 | 2.31-14.2 | <.001 | |||||
| Age | 200 | 146 | 1.01 | 1.00-1.02 | .033 | |||||
| Prednisone, mg/kg | 200 | 146 | 1.92 | 1.09-3.38 | .032 | |||||
| Lung involvement | 200 | 146 | 1.58 | 1.10-2.28 | .016 | |||||
| Characteristic . | 6-mo ORR (CR/PR) . | FFS . | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| n . | Event, n . | OR . | 95% CI . | P value . | n . | Event, n . | HR . | 95% CI . | P value . | |
| Liver involvement | 131 | 59 | 5.49 | 2.31-14.2 | <.001 | |||||
| Age | 200 | 146 | 1.01 | 1.00-1.02 | .033 | |||||
| Prednisone, mg/kg | 200 | 146 | 1.92 | 1.09-3.38 | .032 | |||||
| Lung involvement | 200 | 146 | 1.58 | 1.10-2.28 | .016 | |||||
OR, odds ratio.